Full name
SUPRAMED SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
SUPRAMED SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. BIAŁY KAMIEŃ 1 / 1U, 02-593 WARSZAWA
TAX ID5213664169
Rate company:
SUPRAMED SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID5213664169
KRS0000492140
Share capital10,000.00 zł
address
UL. BIAŁY KAMIEŃ 1 / 1U, 02-593 WARSZAWA
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
5213664169
REGON
147051970
KRS
0000492140
Legal form
limited liability company
Register Address
UL. BIAŁY KAMIEŃ 1 / 1U, 02-593 WARSZAWA
Date of registration in KRS
2013-12-31
Date of commencement of economic activity
2013-12-31
Act signature
RDF/736695/25/317
Pkd codes
86.22.Z - Specialist medical practice
32.50.Z - Production of medical devices, instruments, and products, including dental products
33.13.Z - Repair and maintenance of electronic and optical devices
47.74.Z - Retail sale of medical and orthopedic products
68.20.Z - Rental and management of own or leased real estate
72.11.Z - Scientific research and development activities
77.11.Z - Rental and leasing of passenger cars and light motor vehicles
84.12.Z - Management of public services in health, education, culture, and other social services
86.10.Z - Hospital activities
86.90.E - Healthcare
Payer VAT status
Active
Vat list bank account(s)
PL19 1140 2004 0000 3902 8172 6574 
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss)  | -220,3 | 54,1 | -228,4 | -522,5 |
EBITDA | -220,3 | 55 | -209,7 | -481,6 |
Short time liabilities | 283,5 | 181,3 | 402,2 | 121,8 |
Equity capital | -215,3 | -156,3 | -384,7 | -146,1 |
Operating profit (EBIT) | -220,3 | 55 | -211,7 | -485,2 |
Assets | 69,8 | 25 | 17,5 | -30,1 |
Net profit (loss) | -220,3 | 54,1 | -228,4 | -522,5 |
Cash | 7,9 | 5,5 | 1,7 | -68,4 |
Net income from sale | 9,8 | 150 | 207,5 | 38,3 |
Liabilities and provisions for liabilities | 285,2 | 181,3 | 402,2 | 121,8 |
Working assets | 69,8 | 25 | 17,5 | -30,1 |
Depreciation | 0 | 0 | 2 | -∞ |
% | % | % | p.p. | |
Profitability of capital | 102,3 | -34,6 | 59,4 | 94 |
Equity capital to total assets | -308,4 | -624,8 | -2200,6 | -1575,8 |
Gross profit margin | -2258,5 | 36 | -110,1 | -146,1 |
EBITDA Margin | -2258,5 | 36,6 | -101,1 | -137,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 10 607 | 441 | 708 | 267 |
Current financial liquidity indicator | 0.24484752118587494 | 0.13796372711658478 | 0.043467797338962555 | -0,1 |
Net dept to EBITDA | -1.244999885559082 | 3.1122143268585205 | -1.6130626201629639 | -4,7 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Activity report
Download pdf01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdfShow more (2)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
Med+reh Filip Pałczyński
Września